ClinicalTrials.gg
Drug

Parsaclisib clinical trials

Also written INCB050465 and IBI376.

studies test it
33
open now
2
in phase 3
5
first study started
2015

How each study uses parsaclisib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the parsaclisib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Parsaclisib
27
(4R)-4-(3-((1S)-1-(4-Amino-3-methyl-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one
2

Development codes

INCB050465
27
IBI376
6
WHO 10589
2

Studies by the year they started

33 studies that test it; most in 2021 (7)

Studies that test parsaclisib, by start year
YearStudies
20151
20162
20175
20185
20192
20205
20217
20225
20231

Who runs them

Industry 27 · Other 6

Incyte Corporation (24) · Innovent Biologics (Suzhou) Co. Ltd. (2) · Mayo Clinic (1) · Walter Hanel (1) · Incyte Biosciences Japan GK (1) · Fudan University (1) · Chinese PLA General Hospital (1) · Henan Cancer Hospital (1)

Often tested with

Tested in the same studies.

Itacitinib (2) · Rituximab (2) · Epacadostat (2) · Cyclophosphamide (1) · Doxorubicin (1) · Prednisone (1) · Vincristine (1) · Romidepsin (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test parsaclisib.

Studies

Open first, then newest update. How each study uses parsaclisib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 33

See all 33 studies that test parsaclisib →

Given beside what is tested · 3 — parsaclisib is usual care or a partner of the new treatment

Codes

What other systems call parsaclisib · ClinicalTrials.gg INT001234

  • MeSH (NLM) C000656179parsaclisibConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) OS7097575KPARSACLISIBConfirmed FDA, NLM, Wikidata
  • Wikidata Q76802661parsaclisibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C113434ParsaclisibOne source FDA
  • DrugBank DB14867One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.